• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center


    Thinking therapeutically: Scientists in search of smarter tests and treatments for prostate cancer

    Even though prostate cancer is the second leading cause of cancer death in men in the United States, some patients may wonder whether treatment is worse than the disease

    Beyond survival: Bettering menís quality of life following prostate cancer treatment

    Few clinicians understand the consequences of prostate cancer treatment better than urological surgeon-scientist Martin Sanda, MD, director of the multidisciplinary prostate cancer clinic at BIDMC

    Unique randomized trial tests VEGF inhibitor in patients with recurrent glioblastoma

    Glioblastoma, the most common and lethal type of malignant brain tumor, has a poor prognosis and very few chemotherapeutic options

    Health Communication Core

    The Health Communication Core provides communication support to members in areas such as cancer prevention education and communication, recruitment to clinical research studies, and public outreach

    Elias Zerhouni, MD, Director of NIH, to step down in late October
    Twelve New Members Join DF/HCC

    Twelve individuals have recently joined DF/HCC

    DF/HCC Nodal Awards announced

    DF/HCC offers a multitude of funding opportunities to its members to encourage and enhance the collaborative spirit of research within the Harvard medical community

Displaying results 127 to 133 out of 207